BibTex RIS Cite
Year 2009, Volume: 1 Issue: 1, 2 - 6, 01.04.2009

Abstract

References

  • Bacon PA, Moots RJ. Extra-articular rheumatoid arthritis. In: Kopman WJ (Ed). Arthritis and Allied Conditions. 13 th Ed, Pennsylvania: Williams and Wilkins, 1997; 71, 1088.
  • Dedhia HV, DiBartolomeo A. Rheumatoid arthritis. Review.Crit Care Clin 2002;18:841-854.
  • Sattar N, McCarey WD, Capell H et al. Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation 2003;108: 2957- 2963.
  • Mutru O, Laakso M, Isomaki H, Koota K. Cardiovascular mortality in patients with rheumatoid arthritis. Cardiology 1989;76: 71ñ77.
  • Del Rincon I, Oíleary DH, Freeman GL, Escalante A. Acceleration of atherosclerosis during the course of rheumatoid arthritis. Atherosclerosis 2007;195:354-360.
  • Gonzalez-Gay MA, Gonzalez-Juanatey C, Martin J. Rheumatoid arthritis: a disease associated with accelerated atherogenesis. Semin Arthritis Rheum 2005;35:8-17.
  • del Rincon ID, Williams K, Stern MP, Freeman GL, Escalante A. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 2001;44:2737-2745.
  • Dessein PH, Joffe BI, Veller MG et al. Traditional and nontraditional cardiovascular risk factors are associated with atherosclerosis in rheumatoid arthritis. J Rheumatol 2005;32:435-442.
  • Nurmohamed MT. Atherogenic lipid profiles and its management in patients with rheumatoid arthritis. Vasc Health Risk Manag 2007;3:845-852.
  • Dursunoðlu D, Evreng¸l E, Polat B ve ark. Romatoid artritli hastalarda lipoprotein (a) ve lipidler: serum d¸zeyleri ve inflamasyonla iliºkisi. MN-Kardiyoloji Dergisi 2003;10:277-282.
  • G¸r A, Nas K, «olpan L, «evik R, Erdoðan F, SaraÁ A. Romatoid Artritli Hastalarda Kardiyak Mortaliteden Sorumlu Faktˆr Serum Lipid Profilindeki Deðiºimler midir? T¸rkiye Fiziksel T˝p ve Rehabilitasyon Dergisi 1999;2:18-26.
  • Rexhepaj N, Bajraktari G, Berisha I et al. Left and right ventricular diastolic functions in patients with rheumatoid arthritis without clinically evident cardiovascular disease. Int J Clin Pract 2006;60:683-688.
  • Wislowska M, Jaszczyk B, KochmaÒski M, Sypu˘a S, Sztechman M. Diastolic heart function in RA patients. Rheumatol Int 2008;28: 513-519.
  • McMahon M, Grossman J, FitzGerald J et al. Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 2006;54:2541-2549.
  • Park YB, Lee SK, Lee WK et al. Lipid profiles in untreated patients with rheumatoid arthritis. J Rheumatol 1999;26:1701-1704.
  • White D, Fayez S, Doube A. Atherogenic lipid profiles in rheumatoid arthritis. NZ Med J 2006;119:U21-25
  • Manzi S, Wasko MC. Inflammation-mediated rheumatic diseases and atherosclerosis. Ann Rheum Dis 2000;59:321-325.
  • van Halm VP, Nielen MM, Nurmohamed MT et al. Lipids and inflammation: serial measurements of the lipid profile of blood donors who later developed rheumatoid arthritis. Ann Rheum Dis 2007;66:184-188.
  • Gonzalez-Gay MA, Gonzalez-Juanatey C, Pineiro A, Garcia-Porrua C, Testa A, Llorca J. High-grade C-reactive protein elevation correlates with accelerated atherogenesis in patients with rheumatoid arthritis. J Rheumatol 2005;32:1219-1223.
  • Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-324.
  • Boers M, Nurmohammed MT, Doelman CJ et al. Influence of glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritis. Ann Rheum Dis 2003;62: 842ñ845.
  • Shoenfeld Y, Gerli R, Doria A et al. Accelerated atherosclerosis in autoimmune rheumatic diseases. Circulation 2005;112: 3337ñ3347.
  • Snow MH, Mikuls TR. Rheumatoid arthritis and cardiovascular disease: the role of systemic inflammation and evolving strategies of prevention. Curr Opin Rheumatol 2005;17: 234ñ241.
  • Popa C, van den Hoogen FH, Radstake TR et al. Modulation of lipoprotein plasma concentrations during long-term anti-TNF therapy in patients with active rheumatoid arthritis. Ann Rheum Dis 2007;66:1503ñ1507.
  • James RW. A long and winding road: defining the biological role and clinical importance of paraoxonases. Clin Chem Lab Med 2006;44:1052-1059.
  • Park YB, Ahn CW, Choi HK et al. Atherosclerosis in rheumatoid arthritis: morphologic evidence obtained by carotid ultrasound. Arthritis Rheum 2002;46:1714-1719.
  • Sherer Y. Shoenfeld Y. Mechanisms of disease: atherosclerosis in autoimmune diseases. Nat Clin Pract Rheumatol 2006;2:99-106.
  • Van Doornum S, Mc Coll G, Wicks IP. Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis? Arthritis Rheum 2002;46:862ñ873.

Romatoid Artritli Hastalarda Lipid Parametrelerinin Değerlendirilmesi

Year 2009, Volume: 1 Issue: 1, 2 - 6, 01.04.2009

Abstract

Amaç: Bu çalýºmada romatoid artritli hastalarda serum lipid parametrelerinin düzeyi ve bunlarýn hastalýk aktivitesi ile iliºkisi araºtýrýldý. Materyal ve Metot: Çalýºmamýza 46 RA hastasý ve 31 saðlýklý birey dahil edildi. Hastalýk süresi 0 ile 12 yýl arasýnda (ortalama 4.2± 4.3 yýl) idi. Her iki grupta da plazma trigliserid (TG), total kolesterol (TK), LDL kolesterol (LDL-K), HDL kolesterol (HDL-K) ölçümleri yapýldý. Ayrýca RA grubundaki hastalarda serum yüksek duyarlýklý CRP, CRP, eritrosit sedimentasyon hýzý (ESH) ve romatoid faktör ölçümleri yapýldý. Bulgular: RA grubu ile kontrol grubu karºýlaºtýrýldýðýnda, serum TG seviyeleri sýrasýyla 134±76 mg/dl ve 179±113mg/dl (p=0.310), serum TK seviyeleri 176±36 mg/dl ve 195±49 mg/dl (p=0.320), serum LDLK seviyeleri 103±33mg/dl ve 116±41mg/dl (p=0.420), serum HDL-K seviyeleri 50±15mg/dl ve 47±12mg/dl (p=0.570) olarak bulundu. Yapýlan korelasyon analizinde herhangi bir lipit parametresi ile CRP ve ESH arasýnda anlamlý bir iliºki saptanmadý. Sonuç: RA hastalarý ile saðlýklý bireyler karºýlaºtýrýldýðýnda lipit parametreleri benzer bulundu. Ayrýca hastalýðýn aktivitesi ile lipid parametreleri arasýnda da anlamlý bir iliºki bulunamadý

References

  • Bacon PA, Moots RJ. Extra-articular rheumatoid arthritis. In: Kopman WJ (Ed). Arthritis and Allied Conditions. 13 th Ed, Pennsylvania: Williams and Wilkins, 1997; 71, 1088.
  • Dedhia HV, DiBartolomeo A. Rheumatoid arthritis. Review.Crit Care Clin 2002;18:841-854.
  • Sattar N, McCarey WD, Capell H et al. Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation 2003;108: 2957- 2963.
  • Mutru O, Laakso M, Isomaki H, Koota K. Cardiovascular mortality in patients with rheumatoid arthritis. Cardiology 1989;76: 71ñ77.
  • Del Rincon I, Oíleary DH, Freeman GL, Escalante A. Acceleration of atherosclerosis during the course of rheumatoid arthritis. Atherosclerosis 2007;195:354-360.
  • Gonzalez-Gay MA, Gonzalez-Juanatey C, Martin J. Rheumatoid arthritis: a disease associated with accelerated atherogenesis. Semin Arthritis Rheum 2005;35:8-17.
  • del Rincon ID, Williams K, Stern MP, Freeman GL, Escalante A. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 2001;44:2737-2745.
  • Dessein PH, Joffe BI, Veller MG et al. Traditional and nontraditional cardiovascular risk factors are associated with atherosclerosis in rheumatoid arthritis. J Rheumatol 2005;32:435-442.
  • Nurmohamed MT. Atherogenic lipid profiles and its management in patients with rheumatoid arthritis. Vasc Health Risk Manag 2007;3:845-852.
  • Dursunoðlu D, Evreng¸l E, Polat B ve ark. Romatoid artritli hastalarda lipoprotein (a) ve lipidler: serum d¸zeyleri ve inflamasyonla iliºkisi. MN-Kardiyoloji Dergisi 2003;10:277-282.
  • G¸r A, Nas K, «olpan L, «evik R, Erdoðan F, SaraÁ A. Romatoid Artritli Hastalarda Kardiyak Mortaliteden Sorumlu Faktˆr Serum Lipid Profilindeki Deðiºimler midir? T¸rkiye Fiziksel T˝p ve Rehabilitasyon Dergisi 1999;2:18-26.
  • Rexhepaj N, Bajraktari G, Berisha I et al. Left and right ventricular diastolic functions in patients with rheumatoid arthritis without clinically evident cardiovascular disease. Int J Clin Pract 2006;60:683-688.
  • Wislowska M, Jaszczyk B, KochmaÒski M, Sypu˘a S, Sztechman M. Diastolic heart function in RA patients. Rheumatol Int 2008;28: 513-519.
  • McMahon M, Grossman J, FitzGerald J et al. Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 2006;54:2541-2549.
  • Park YB, Lee SK, Lee WK et al. Lipid profiles in untreated patients with rheumatoid arthritis. J Rheumatol 1999;26:1701-1704.
  • White D, Fayez S, Doube A. Atherogenic lipid profiles in rheumatoid arthritis. NZ Med J 2006;119:U21-25
  • Manzi S, Wasko MC. Inflammation-mediated rheumatic diseases and atherosclerosis. Ann Rheum Dis 2000;59:321-325.
  • van Halm VP, Nielen MM, Nurmohamed MT et al. Lipids and inflammation: serial measurements of the lipid profile of blood donors who later developed rheumatoid arthritis. Ann Rheum Dis 2007;66:184-188.
  • Gonzalez-Gay MA, Gonzalez-Juanatey C, Pineiro A, Garcia-Porrua C, Testa A, Llorca J. High-grade C-reactive protein elevation correlates with accelerated atherogenesis in patients with rheumatoid arthritis. J Rheumatol 2005;32:1219-1223.
  • Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-324.
  • Boers M, Nurmohammed MT, Doelman CJ et al. Influence of glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritis. Ann Rheum Dis 2003;62: 842ñ845.
  • Shoenfeld Y, Gerli R, Doria A et al. Accelerated atherosclerosis in autoimmune rheumatic diseases. Circulation 2005;112: 3337ñ3347.
  • Snow MH, Mikuls TR. Rheumatoid arthritis and cardiovascular disease: the role of systemic inflammation and evolving strategies of prevention. Curr Opin Rheumatol 2005;17: 234ñ241.
  • Popa C, van den Hoogen FH, Radstake TR et al. Modulation of lipoprotein plasma concentrations during long-term anti-TNF therapy in patients with active rheumatoid arthritis. Ann Rheum Dis 2007;66:1503ñ1507.
  • James RW. A long and winding road: defining the biological role and clinical importance of paraoxonases. Clin Chem Lab Med 2006;44:1052-1059.
  • Park YB, Ahn CW, Choi HK et al. Atherosclerosis in rheumatoid arthritis: morphologic evidence obtained by carotid ultrasound. Arthritis Rheum 2002;46:1714-1719.
  • Sherer Y. Shoenfeld Y. Mechanisms of disease: atherosclerosis in autoimmune diseases. Nat Clin Pract Rheumatol 2006;2:99-106.
  • Van Doornum S, Mc Coll G, Wicks IP. Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis? Arthritis Rheum 2002;46:862ñ873.
There are 28 citations in total.

Details

Primary Language Turkish
Journal Section Articles
Authors

Yazıcı S This is me

Publication Date April 1, 2009
Published in Issue Year 2009 Volume: 1 Issue: 1

Cite

APA S, Y. (2009). Romatoid Artritli Hastalarda Lipid Parametrelerinin Değerlendirilmesi. Konuralp Medical Journal, 1(1), 2-6.
AMA S Y. Romatoid Artritli Hastalarda Lipid Parametrelerinin Değerlendirilmesi. Konuralp Medical Journal. April 2009;1(1):2-6.
Chicago S, Yazıcı. “Romatoid Artritli Hastalarda Lipid Parametrelerinin Değerlendirilmesi”. Konuralp Medical Journal 1, no. 1 (April 2009): 2-6.
EndNote S Y (April 1, 2009) Romatoid Artritli Hastalarda Lipid Parametrelerinin Değerlendirilmesi. Konuralp Medical Journal 1 1 2–6.
IEEE Y. S, “Romatoid Artritli Hastalarda Lipid Parametrelerinin Değerlendirilmesi”, Konuralp Medical Journal, vol. 1, no. 1, pp. 2–6, 2009.
ISNAD S, Yazıcı. “Romatoid Artritli Hastalarda Lipid Parametrelerinin Değerlendirilmesi”. Konuralp Medical Journal 1/1 (April 2009), 2-6.
JAMA S Y. Romatoid Artritli Hastalarda Lipid Parametrelerinin Değerlendirilmesi. Konuralp Medical Journal. 2009;1:2–6.
MLA S, Yazıcı. “Romatoid Artritli Hastalarda Lipid Parametrelerinin Değerlendirilmesi”. Konuralp Medical Journal, vol. 1, no. 1, 2009, pp. 2-6.
Vancouver S Y. Romatoid Artritli Hastalarda Lipid Parametrelerinin Değerlendirilmesi. Konuralp Medical Journal. 2009;1(1):2-6.